Home NDC 0378-5437 Memantine Hydrochloride
Product NDC 0378-5437
11-digit product format 003785437
Labeler code 0378
Product ID 0378-5437_642189b4-b4ad-424a-9c89-4dcbde5b2773
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name memantine
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Mylan Pharmaceuticals Inc.
Application ANDA206032
Marketing category ANDA
Marketing start 2018-02-21
Marketing end 0000-00-00
Substance MEMANTINE HYDROCHLORIDE
Active strength 21 mg/1
Pharmacologic classes NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206032-001 MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE 7MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 A206032-002 MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE 14MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 A206032-003 MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE 21MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 A206032-004 MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE 28MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A206032-001 MEMANTINE HYDROCHLORIDE 7MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 a50c72e98297…2026-08-01 22:54:32 2026-06 A206032-002 MEMANTINE HYDROCHLORIDE 14MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 a50c72e98297…2026-08-01 22:54:32 2026-06 A206032-003 MEMANTINE HYDROCHLORIDE 21MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 a50c72e98297…2026-08-01 22:54:32 2026-06 A206032-004 MEMANTINE HYDROCHLORIDE 28MG CAPSULE, EXTENDED RELEASE / ORAL AB 2016-09-28 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0378-5437-93 00378543793 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-5437-93) 2018-02-21 0000-00-00 No No Current